Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 26 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

23%

6 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(40.0%)
Phase 4
6(30.0%)
Phase 1
3(15.0%)
Phase 2
2(10.0%)
Early Phase 1
1(5.0%)
20Total
N/A(8)
Phase 4(6)
Phase 1(3)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT07565727Recruiting

Cardiometabolic Disease and Substrate Metabolism

Role: lead

NCT06125704Not ApplicableCompleted

Time to Move in Pregnancy Hyperglycemia

Role: collaborator

NCT07223437Not ApplicableRecruiting

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

Role: lead

NCT07393633Completed

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

Role: lead

NCT06039319Completed

Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy

Role: lead

NCT07214012Not ApplicableNot Yet Recruiting

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

Role: lead

NCT07205068Not ApplicableRecruiting

Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure

Role: lead

NCT06802861Recruiting

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

Role: lead

NCT07153614Not ApplicableRecruiting

Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy

Role: lead

NCT07133880Phase 4Recruiting

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

Role: lead

NCT06907849Phase 2Enrolling By Invitation

124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome

Role: lead

NCT06953635Not ApplicableNot Yet Recruiting

Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair

Role: lead

NCT06800105Recruiting

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

Role: lead

NCT05968846Phase 2Completed

Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load

Role: lead

NCT06669650Phase 4Active Not Recruiting

Personalized Post-Operative Pain Management

Role: lead

NCT06449365Phase 4Completed

Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy

Role: lead

NCT05951816Phase 1Unknown

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

Role: lead

NCT04655170Phase 4Unknown

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD

Role: lead

NCT05467241Not ApplicableCompleted

A Novel Therapeutic Approach to Treat Chronic Pelvic Pain

Role: lead

NCT05378659Unknown

Neuroinflammation and Alzheimer's Pathology in POCD

Role: lead